Lv12
75 积分 2023-04-24 加入
Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis
3小时前
已完结
The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes
5小时前
求助中
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
1天前
已完结
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease
14天前
已完结
Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials
21天前
已完结
The research of dapagliflozin on cognitive function in middle-aged and older patients with type 2 diabetes mellitus and mild cognitive impairment: a 36-week prospective parallel control study
28天前
已完结
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease
1个月前
已完结
Dialysis and cognitive impairment
2个月前
已完结
Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD
4个月前
已关闭
Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD
4个月前
已关闭
皖公网安备34019202002308
